Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias R Benz

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Radiation Oncology (London, England)|November 2, 2012
Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coilHans Christian Rischke, Arnd O Schäfer, Ursula Nestle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumabAntoni Ribas, Matthias R Benz, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic TypeKoichiro Kimura, Masha J Livhits, Israa A Laklouk, et al.
Cancer|November 20, 2009
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benignMatthias R Benz, Johannes Czernin, Sarah M Dry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinibMatthias R Benz, Ken Herrmann, Franziska Walter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 15, 2011
Metabolic imaging allows early prediction of response to vandetanibMartin A Walter, Matthias R Benz, Isabel J Hildebrandt, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Cancer|October 25, 2011
3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic responseMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
18F-FDOPA PET and PET/CT accurately localize pheochromocytomasFarzin Imani, Vatche G Agopian, Martin S Auerbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|November 2, 2012
Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coilHans Christian Rischke, Arnd O Schäfer, Ursula Nestle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumabAntoni Ribas, Matthias R Benz, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic TypeKoichiro Kimura, Masha J Livhits, Israa A Laklouk, et al.
Cancer|November 20, 2009
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benignMatthias R Benz, Johannes Czernin, Sarah M Dry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinibMatthias R Benz, Ken Herrmann, Franziska Walter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 15, 2011
Metabolic imaging allows early prediction of response to vandetanibMartin A Walter, Matthias R Benz, Isabel J Hildebrandt, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Cancer|October 25, 2011
3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic responseMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
18F-FDOPA PET and PET/CT accurately localize pheochromocytomasFarzin Imani, Vatche G Agopian, Martin S Auerbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Pageof 6